Tutul Chowdhury
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tutul Chowdhury has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Nicole Gousy
Medicine, American University of Antigua, New York, USA
7 shared publications - Arjun Mainali
Internal Medicine, One Brooklyn Health System, Brooklyn, USA
5 shared publications Minhaz Murshad
5 shared publicationsAditi Parulkar
Internal Medicine, One Brooklyn Health, Interfaith Medical Center, New York, USA
4 shared publicationsAmulya Bellamkonda
Internal Medicine, One Brooklyn Health-Interfaith Medical Center, Brooklyn, USA
4 shared publicationsAnusha Akella
Internal Medicine, One Brooklyn Health, Interfaith Medical Center, New York, USA
4 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Severe Central Nervous System Co-infection With Streptococcus pneumoniae and Varicella-Zoster Virus Presenting as Meningoencephalitis
Prompt identification of bacterial and viral central nervous system (CNS) infections is crucial; however, co-infection remains rare and diagnostically challenging. We report the case of a 61-year-old woman who presented with altered mental status and was initially suspected of having a stroke but was later diagnosed with severe sepsis and meningitis. Cerebrospinal fluid (CSF) analysis revealed elevated protein levels, and nucleic acid amplification testing (NAAT) identified concurrent Streptococcus pneumoniae and varicella-zoster virus (VZV) infection. Blood cultures subsequently confirmed S. pneumoniae bacteremia. Furthermore, the hospital course was complicated by metabolic encephalopathy, non-ST-segment elevation myocardial infarction (NSTEMI), and acute kidney injury (AKI). This case highlights the importance of maintaining a broad differential diagnosis and considering mixed CNS infections in atypical presentations while emphasizing the value of molecular testing. Early recognition and targeted therapy are essential for improving neurological outcomes in critically ill patients.
- 8 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Open AccessSevere Central Nervous System Co-infection With Streptococcus pneumoniae and Varicella-Zoster Virus Presenting as Meningoencephalitis
Prompt identification of bacterial and viral central nervous system (CNS) infections is crucial; however, co-infection remains rare and diagnostically challenging. We report the case of a 61-year-old woman who presented with altered mental status and was initially suspected of having a stroke but was later diagnosed with severe sepsis and meningitis. Cerebrospinal fluid (CSF) analysis revealed elevated protein levels, and nucleic acid amplification testing (NAAT) identified concurrent Streptococcus pneumoniae and varicella-zoster virus (VZV) infection. Blood cultures subsequently confirmed S. pneumoniae bacteremia. Furthermore, the hospital course was complicated by metabolic encephalopathy, non-ST-segment elevation myocardial infarction (NSTEMI), and acute kidney injury (AKI). This case highlights the importance of maintaining a broad differential diagnosis and considering mixed CNS infections in atypical presentations while emphasizing the value of molecular testing. Early recognition and targeted therapy are essential for improving neurological outcomes in critically ill patients.
- Open Access
- 18 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Wunderlich Syndrome: A Rare Case of Spontaneous Perinephric Hemorrhage
Wunderlich syndrome is a rare urological emergency characterized by spontaneous, nontraumatic renal hemorrhage into the subcapsular and perirenal spaces. We present the case of a 37-year-old male with end-stage renal disease on hemodialysis, hypertension, and bilateral inguinal hernias who presented with acute chest and abdominal pain, nausea, and vomiting after missing a dialysis session. The initial assessment identified severe anemia necessitating a massive transfusion, and he was subsequently treated for suspected uremic coagulopathy. Imaging with computed tomography angiography (CTA) demonstrated a massive left retroperitoneal hemorrhage. The patient also tested positive for COVID-19, potentially contributing to a complex coagulopathic state. Given ongoing bleeding, he underwent successful renal artery embolization, achieving hemostasis without surgical intervention. This case highlights the importance of early recognition of Wunderlich syndrome in high-risk patients, the diagnostic value of CTA, and the critical role of interventional radiology in management.
- 18 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessWunderlich Syndrome: A Rare Case of Spontaneous Perinephric Hemorrhage
Wunderlich syndrome is a rare urological emergency characterized by spontaneous, nontraumatic renal hemorrhage into the subcapsular and perirenal spaces. We present the case of a 37-year-old male with end-stage renal disease on hemodialysis, hypertension, and bilateral inguinal hernias who presented with acute chest and abdominal pain, nausea, and vomiting after missing a dialysis session. The initial assessment identified severe anemia necessitating a massive transfusion, and he was subsequently treated for suspected uremic coagulopathy. Imaging with computed tomography angiography (CTA) demonstrated a massive left retroperitoneal hemorrhage. The patient also tested positive for COVID-19, potentially contributing to a complex coagulopathic state. Given ongoing bleeding, he underwent successful renal artery embolization, achieving hemostasis without surgical intervention. This case highlights the importance of early recognition of Wunderlich syndrome in high-risk patients, the diagnostic value of CTA, and the critical role of interventional radiology in management.
- Open Access
- 9 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Silent Superior Mesenteric Artery Dissection Discovered During Hypertensive Emergency With Acute Pulmonary Edema in an End-Stage Renal Disease Patient
Isolated superior mesenteric artery (SMA) dissection is a rare vascular condition that is increasingly recognized due to the widespread use of advanced imaging modalities. It may present with abdominal pain or remain asymptomatic and be detected incidentally. We report the case of a 62-year-old male with end-stage renal disease (ESRD) on hemodialysis who presented with hypertensive emergency and acute pulmonary edema, in whom SMA dissection was incidentally identified on computed tomography angiography (CTA). The patient was successfully managed conservatively with blood pressure control, antithrombotic therapy, and close monitoring. This case highlights the importance of individualized management strategies in asymptomatic SMA dissection and supports the role of conservative therapy in stable patients without evidence of bowel ischemia.
- 9 April 2026
- Published by Springer Nature in Cureus
- Vol. 18 (4)
Open AccessSilent Superior Mesenteric Artery Dissection Discovered During Hypertensive Emergency With Acute Pulmonary Edema in an End-Stage Renal Disease Patient
Isolated superior mesenteric artery (SMA) dissection is a rare vascular condition that is increasingly recognized due to the widespread use of advanced imaging modalities. It may present with abdominal pain or remain asymptomatic and be detected incidentally. We report the case of a 62-year-old male with end-stage renal disease (ESRD) on hemodialysis who presented with hypertensive emergency and acute pulmonary edema, in whom SMA dissection was incidentally identified on computed tomography angiography (CTA). The patient was successfully managed conservatively with blood pressure control, antithrombotic therapy, and close monitoring. This case highlights the importance of individualized management strategies in asymptomatic SMA dissection and supports the role of conservative therapy in stable patients without evidence of bowel ischemia.
- Open Access
- 6 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Dual Mycobacterial Infection: Rare Coinfection of Mycobacterium tuberculosis and Nontuberculous Mycobacteria
There is little research on the subject, despite the rising prevalence of concurrent Mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) infections. We present the case of a 48-year-old immunocompetent man diagnosed with pulmonary tuberculosis with simultaneous sputum cultures positive for NTM. Chest imaging revealed bilateral upper-lobe cavitary lesions, and serial sputum studies demonstrated persistent MTB on acid-fast bacilli smears and MTB polymerase chain reaction. Standard four-drug antituberculous therapy was initiated. However, concurrent sputum cultures subsequently grew Mycobacterium abscessus and later Mycobacterium avium complex, prompting the addition of amikacin, cefoxitin, and azithromycin based on infectious disease consultation. This case illustrates the diagnostic and therapeutic challenges inherent to MTB-NTM coinfection, where distinguishing true NTM disease from colonization is critical, and underscores the importance of multidisciplinary management.
- 6 January 2026
- Published by Springer Nature in Cureus
- Vol. 18 (1)
Open AccessDual Mycobacterial Infection: Rare Coinfection of Mycobacterium tuberculosis and Nontuberculous Mycobacteria
There is little research on the subject, despite the rising prevalence of concurrent Mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) infections. We present the case of a 48-year-old immunocompetent man diagnosed with pulmonary tuberculosis with simultaneous sputum cultures positive for NTM. Chest imaging revealed bilateral upper-lobe cavitary lesions, and serial sputum studies demonstrated persistent MTB on acid-fast bacilli smears and MTB polymerase chain reaction. Standard four-drug antituberculous therapy was initiated. However, concurrent sputum cultures subsequently grew Mycobacterium abscessus and later Mycobacterium avium complex, prompting the addition of amikacin, cefoxitin, and azithromycin based on infectious disease consultation. This case illustrates the diagnostic and therapeutic challenges inherent to MTB-NTM coinfection, where distinguishing true NTM disease from colonization is critical, and underscores the importance of multidisciplinary management.
- Open Access
- 10 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Fatal Multiorgan Dysfunction Syndrome Secondary to Cocaine Toxicity
Cocaine toxicity is a well-recognized cause of multiorgan dysfunction due to its potent sympathomimetic, vasoconstrictive, and prothrombotic effects. Severe cases can result in cardiogenic shock, rhabdomyolysis, acute kidney injury (AKI), and acute hepatic failure. We describe a case of a 50-year-old female with a history of substance use disorder who presented with cocaine intoxication, unresponsive to naloxone, and required intubation. She developed distributive shock requiring triple vasopressor support and suffered recurrent cardiac arrests with temporary return of circulation. Laboratory findings showed rhabdomyolysis (creatine kinase (CK) 29,074), AKI (creatinine 5.8 mg/dL), elevated troponins (9,978 ng/L), severe metabolic acidosis, and hepatic injury. Despite continuous renal replacement therapy (CRRT), empiric broad-spectrum antibiotics, and maximal supportive care, she remained comatose with progressive multiorgan failure and expired on hospital day three. This report underscores the severe systemic and often fatal complications of cocaine toxicity.
- 10 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessFatal Multiorgan Dysfunction Syndrome Secondary to Cocaine Toxicity
Cocaine toxicity is a well-recognized cause of multiorgan dysfunction due to its potent sympathomimetic, vasoconstrictive, and prothrombotic effects. Severe cases can result in cardiogenic shock, rhabdomyolysis, acute kidney injury (AKI), and acute hepatic failure. We describe a case of a 50-year-old female with a history of substance use disorder who presented with cocaine intoxication, unresponsive to naloxone, and required intubation. She developed distributive shock requiring triple vasopressor support and suffered recurrent cardiac arrests with temporary return of circulation. Laboratory findings showed rhabdomyolysis (creatine kinase (CK) 29,074), AKI (creatinine 5.8 mg/dL), elevated troponins (9,978 ng/L), severe metabolic acidosis, and hepatic injury. Despite continuous renal replacement therapy (CRRT), empiric broad-spectrum antibiotics, and maximal supportive care, she remained comatose with progressive multiorgan failure and expired on hospital day three. This report underscores the severe systemic and often fatal complications of cocaine toxicity.
- Open Access
- 20 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
A Rare Case of Multilevel Pott’s Disease With Coexistent Pulmonary Cavitary Tuberculosis and Neurogenic Bladder
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is an infection that typically affects the lungs and is a common cause of morbidity and mortality around the world. Primary TB infection, or latent TB, is often asymptomatic; immunocompromised patients are more at risk of TB disease, which manifests with fever, fatigue, unexplained weight loss, night sweats, and productive cough. Although not common, infection can spread hematogenously to other parts of the body (e.g., kidneys and spine) and lead to extrapulmonary TB. Diagnosis made through microscopic examination for acid-fast bacilli (AFB), nucleic acid amplification test (NAAT), and mycobacterial culture is the gold standard. For extrapulmonary TB, additional invasive procedures, e.g., biopsy, are required for bacteriological confirmation. We report a case of suspected Pott's disease (spine TB) in a 21-year-old patient, who presented with back pain and lower-extremity weakness, and was found to have a spinal mass; biopsy revealed caseating granulomas. Multiple diagnostic studies failed to identify mycobacteria. Although no active TB history was reported, computed tomography (CT) of the lungs showed a cavitary lesion in the left upper lobe. The patient's condition improved after undergoing neurosurgical intervention and initiating rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE) therapy.
- 20 November 2025
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Open AccessA Rare Case of Multilevel Pott’s Disease With Coexistent Pulmonary Cavitary Tuberculosis and Neurogenic Bladder
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is an infection that typically affects the lungs and is a common cause of morbidity and mortality around the world. Primary TB infection, or latent TB, is often asymptomatic; immunocompromised patients are more at risk of TB disease, which manifests with fever, fatigue, unexplained weight loss, night sweats, and productive cough. Although not common, infection can spread hematogenously to other parts of the body (e.g., kidneys and spine) and lead to extrapulmonary TB. Diagnosis made through microscopic examination for acid-fast bacilli (AFB), nucleic acid amplification test (NAAT), and mycobacterial culture is the gold standard. For extrapulmonary TB, additional invasive procedures, e.g., biopsy, are required for bacteriological confirmation. We report a case of suspected Pott's disease (spine TB) in a 21-year-old patient, who presented with back pain and lower-extremity weakness, and was found to have a spinal mass; biopsy revealed caseating granulomas. Multiple diagnostic studies failed to identify mycobacteria. Although no active TB history was reported, computed tomography (CT) of the lungs showed a cavitary lesion in the left upper lobe. The patient's condition improved after undergoing neurosurgical intervention and initiating rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE) therapy.
- Open Access
- 21 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10) , e95099
A Case of Right Middle Lobe Syndrome: A Rare Diagnosis Behind Chronic Pulmonary Symptoms
Right middle lobe syndrome (RMLS) is an uncommon pulmonary condition characterized by recurrent or chronic atelectasis or infection of the right middle lobe, often due to either obstructive or non-obstructive mechanisms. We present the case of a 62-year-old male with a history of chronic obstructive pulmonary disease (COPD), prediabetes, and prior tobacco use, who presented with mid-sternal chest pain and a chronic dry cough. Imaging revealed right middle lobe collapse without endobronchial obstruction on bronchoscopy. A mucus plug was identified and removed, revealing edematous mucosa but no visible lesions. Cultures grew Streptococcus pneumoniae sensitive to ceftriaxone, while acid-fast bacilli (AFB) and fungal cultures were negative. Pathology demonstrated mild chronic inflammation with no malignancy. The patient responded well to antibiotics and inhaler therapy, with radiologic evidence of partial resolution on follow-up imaging. This case highlights the diagnostic challenges of RMLS in adults and underscores the importance of considering this rare entity in patients with chronic pulmonary symptoms and localized lobe collapse. Early bronchoscopy and appropriate treatment can lead to clinical and radiologic improvement.
- 21 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10) , e95099
Open AccessA Case of Right Middle Lobe Syndrome: A Rare Diagnosis Behind Chronic Pulmonary Symptoms
Right middle lobe syndrome (RMLS) is an uncommon pulmonary condition characterized by recurrent or chronic atelectasis or infection of the right middle lobe, often due to either obstructive or non-obstructive mechanisms. We present the case of a 62-year-old male with a history of chronic obstructive pulmonary disease (COPD), prediabetes, and prior tobacco use, who presented with mid-sternal chest pain and a chronic dry cough. Imaging revealed right middle lobe collapse without endobronchial obstruction on bronchoscopy. A mucus plug was identified and removed, revealing edematous mucosa but no visible lesions. Cultures grew Streptococcus pneumoniae sensitive to ceftriaxone, while acid-fast bacilli (AFB) and fungal cultures were negative. Pathology demonstrated mild chronic inflammation with no malignancy. The patient responded well to antibiotics and inhaler therapy, with radiologic evidence of partial resolution on follow-up imaging. This case highlights the diagnostic challenges of RMLS in adults and underscores the importance of considering this rare entity in patients with chronic pulmonary symptoms and localized lobe collapse. Early bronchoscopy and appropriate treatment can lead to clinical and radiologic improvement.
- Open Access
- 1 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3) , e55325
Sepsis Unveils T-cell Large Granular Lymphocytic Leukemia in the Setting of End-Stage Renal Disease: A Rare Hematologic Malignancy
Large granular lymphocytic (LGL) leukemia is a rare chronic lymphoproliferative disorder originating from natural killer cells or T lymphocytes. In this report, we present the case of a 66-year-old female initially treated for sepsis, with methicillin-sensitive Staphylococcus aureus identified on initial blood culture prompting intravenous (IV) antibiotic therapy. The patient met systemic inflammatory response syndrome criteria upon admission due to severe neutropenia. Persistent fever led to neurological symptoms, and imaging revealed lung abnormalities along with chronic changes on the CT scan of the head. Multidisciplinary consultations were sought, resulting in treatment adjustments including antifungals and filgrastim. Flow cytometry and bone marrow biopsy confirmed the diagnosis of LGL leukemia.
- 1 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3) , e55325
Open AccessSepsis Unveils T-cell Large Granular Lymphocytic Leukemia in the Setting of End-Stage Renal Disease: A Rare Hematologic Malignancy
Large granular lymphocytic (LGL) leukemia is a rare chronic lymphoproliferative disorder originating from natural killer cells or T lymphocytes. In this report, we present the case of a 66-year-old female initially treated for sepsis, with methicillin-sensitive Staphylococcus aureus identified on initial blood culture prompting intravenous (IV) antibiotic therapy. The patient met systemic inflammatory response syndrome criteria upon admission due to severe neutropenia. Persistent fever led to neurological symptoms, and imaging revealed lung abnormalities along with chronic changes on the CT scan of the head. Multidisciplinary consultations were sought, resulting in treatment adjustments including antifungals and filgrastim. Flow cytometry and bone marrow biopsy confirmed the diagnosis of LGL leukemia.
- Open Access
- 22 February 2024
- Published by Springer Nature in Cureus
- Vol. 16 (2) , e54695
Bradycardia, Renal Failure, Atrioventricular Block, Shock, and Hyperkalemia (BRASH) Syndrome Emergence in a Unique Intersection of COVID-19 and End-Stage Renal Disease: A Case Report
Bradycardia, renal failure, atrioventricular (AV) block, shock, and hyperkalemia (BRASH) syndrome is a rare clinical entity that poses challenges for healthcare practitioners. It is characterized by bradycardia, renal failure, atrioventricular (AV) obstruction, shock, and hyperkalemia. This case is an interesting instance of BRASH syndrome in the setting of COVID-19 infection and end-stage renal disease (ESRD). Initial laboratory results revealed macrocytic anemia, renal dysfunction, acidosis, and mild hyponatremia, along with hyperkalemia. An electrocardiogram (EKG) and telemonitoring showed dopamine-resistant persistent bradycardia until transvenous temporary pacemaker placement was done, which resolved the bradycardia. Anti-hyperkalemic therapy, avoiding AV nodal-blocking medication, and temporary pacemaker placement were all part of the management. After receiving hemodialysis, the patient gradually recovered. Bradycardia improved and potassium normalized. The intricate interaction between hyperkalemia and AV nodal obstruction that causes BRASH syndrome results in severe bradycardia and shock. To the best of our knowledge, this is the first case of BRASH syndrome in a patient with an active COVID-19 infection in a previously vaccinated patient. Even though case reports make up the majority of the material currently in publication, to fully comprehend the mechanisms underlying this illness, more research is required, as early detection of this syndrome is crucial for better patient outcomes.
- 22 February 2024
- Published by Springer Nature in Cureus
- Vol. 16 (2) , e54695
Open AccessBradycardia, Renal Failure, Atrioventricular Block, Shock, and Hyperkalemia (BRASH) Syndrome Emergence in a Unique Intersection of COVID-19 and End-Stage Renal Disease: A Case Report
Bradycardia, renal failure, atrioventricular (AV) block, shock, and hyperkalemia (BRASH) syndrome is a rare clinical entity that poses challenges for healthcare practitioners. It is characterized by bradycardia, renal failure, atrioventricular (AV) obstruction, shock, and hyperkalemia. This case is an interesting instance of BRASH syndrome in the setting of COVID-19 infection and end-stage renal disease (ESRD). Initial laboratory results revealed macrocytic anemia, renal dysfunction, acidosis, and mild hyponatremia, along with hyperkalemia. An electrocardiogram (EKG) and telemonitoring showed dopamine-resistant persistent bradycardia until transvenous temporary pacemaker placement was done, which resolved the bradycardia. Anti-hyperkalemic therapy, avoiding AV nodal-blocking medication, and temporary pacemaker placement were all part of the management. After receiving hemodialysis, the patient gradually recovered. Bradycardia improved and potassium normalized. The intricate interaction between hyperkalemia and AV nodal obstruction that causes BRASH syndrome results in severe bradycardia and shock. To the best of our knowledge, this is the first case of BRASH syndrome in a patient with an active COVID-19 infection in a previously vaccinated patient. Even though case reports make up the majority of the material currently in publication, to fully comprehend the mechanisms underlying this illness, more research is required, as early detection of this syndrome is crucial for better patient outcomes.
- Open Access
- 5 October 2023
- Published by Springer Nature in Cureus
- Vol. 15 (10) , e46518
Unmasking the Silent Threat: Cefepime-Induced Thrombocytopenia
Cefepime, a commonly prescribed fourth-generation cephalosporin, is well-known for its broad-spectrum antibacterial activity. While adverse drug reactions associated with cefepime are well documented, thrombocytopenia as a rare complication has gained attention due to its potential severity. Symptomatic patients present with purpura (bruising), petechiae (small red or purple spots on the skin), and mucosal bleeding. Drug-induced thrombocytopenia can be initiated by myelosuppression by halting platelet formation in the bone marrow or by a drug-induced immune thrombocytopenia reaction. We present a case of a 71-year-old male who experienced thrombocytopenia secondary to cefepime use. We further discussed the underlying mechanisms of cefepime-induced thrombocytopenia, highlighting the need for increased vigilance in monitoring platelet counts during cefepime administration. This case underscores the importance of recognizing and managing this uncommon but potentially life-threatening adverse reaction in clinical practice.
- 5 October 2023
- Published by Springer Nature in Cureus
- Vol. 15 (10) , e46518
Open AccessUnmasking the Silent Threat: Cefepime-Induced Thrombocytopenia
Cefepime, a commonly prescribed fourth-generation cephalosporin, is well-known for its broad-spectrum antibacterial activity. While adverse drug reactions associated with cefepime are well documented, thrombocytopenia as a rare complication has gained attention due to its potential severity. Symptomatic patients present with purpura (bruising), petechiae (small red or purple spots on the skin), and mucosal bleeding. Drug-induced thrombocytopenia can be initiated by myelosuppression by halting platelet formation in the bone marrow or by a drug-induced immune thrombocytopenia reaction. We present a case of a 71-year-old male who experienced thrombocytopenia secondary to cefepime use. We further discussed the underlying mechanisms of cefepime-induced thrombocytopenia, highlighting the need for increased vigilance in monitoring platelet counts during cefepime administration. This case underscores the importance of recognizing and managing this uncommon but potentially life-threatening adverse reaction in clinical practice.